中国现代医生
中國現代醫生
중국현대의생
CHINA MODERN DOCTOR
2015年
13期
114-117
,共4页
冠心病%超敏C反应蛋白%D-二聚体
冠心病%超敏C反應蛋白%D-二聚體
관심병%초민C반응단백%D-이취체
Coronary heart disease%High sensitivity C reactive protein%D-dimer
目的:探讨老年冠心病患者超敏C反应蛋白、D-二聚体的关系。方法选取我院老年病科及内科老年冠心病患者162例,根据冠心病不同分型将患者分为稳定型心绞痛组(SAP组)、不稳定型心绞痛组(UAP组)、非ST段抬高性心肌梗死组(NSTEMI组)和ST段抬高性心肌梗死组(STEMI组),全部患者均采用免疫速率法测定血清超敏C反应蛋白水平,免疫比浊法测定D-二聚体水平,分析两者对临床心血管不良事件发生的影响及其与冠脉病变程度(Gensini积分)的关系。结果STEMI组超敏C反应蛋白、D-二聚体水平、单项与联合检测阳性率均明显高于SAP组、UAP组和NSTEMI组,NSTEMI组上述指标均明显高于SAP组和UAP组,UAP组上述指标均明显高于SAP组,组间比较差异有统计学意义(P<0.05),其中联合检测阳性率均明显高于单项检测阳性率,差异显著(P<0.05),高C水平组患者临床心血管不良事件发生率明显高于低C水平组,高D水平组患者临床心血管不良事件发生率明显高于低D水平组,具有显著差异(P<0.05),经Pearson相关分析发现,超敏C反应蛋白与D-二聚体呈正相关(r=0.51,P=0.03),两者均与Gensini积分呈正相关(r=0.46、0.52,P=0.04、0.03)。结论超敏C反应蛋白、D-二聚体在不同老年冠心病分型中差异显著,两者均与冠脉病变程度呈正相关,且对临床心血管不良事件发生具有重要的评估作用。
目的:探討老年冠心病患者超敏C反應蛋白、D-二聚體的關繫。方法選取我院老年病科及內科老年冠心病患者162例,根據冠心病不同分型將患者分為穩定型心絞痛組(SAP組)、不穩定型心絞痛組(UAP組)、非ST段抬高性心肌梗死組(NSTEMI組)和ST段抬高性心肌梗死組(STEMI組),全部患者均採用免疫速率法測定血清超敏C反應蛋白水平,免疫比濁法測定D-二聚體水平,分析兩者對臨床心血管不良事件髮生的影響及其與冠脈病變程度(Gensini積分)的關繫。結果STEMI組超敏C反應蛋白、D-二聚體水平、單項與聯閤檢測暘性率均明顯高于SAP組、UAP組和NSTEMI組,NSTEMI組上述指標均明顯高于SAP組和UAP組,UAP組上述指標均明顯高于SAP組,組間比較差異有統計學意義(P<0.05),其中聯閤檢測暘性率均明顯高于單項檢測暘性率,差異顯著(P<0.05),高C水平組患者臨床心血管不良事件髮生率明顯高于低C水平組,高D水平組患者臨床心血管不良事件髮生率明顯高于低D水平組,具有顯著差異(P<0.05),經Pearson相關分析髮現,超敏C反應蛋白與D-二聚體呈正相關(r=0.51,P=0.03),兩者均與Gensini積分呈正相關(r=0.46、0.52,P=0.04、0.03)。結論超敏C反應蛋白、D-二聚體在不同老年冠心病分型中差異顯著,兩者均與冠脈病變程度呈正相關,且對臨床心血管不良事件髮生具有重要的評估作用。
목적:탐토노년관심병환자초민C반응단백、D-이취체적관계。방법선취아원노년병과급내과노년관심병환자162례,근거관심병불동분형장환자분위은정형심교통조(SAP조)、불은정형심교통조(UAP조)、비ST단태고성심기경사조(NSTEMI조)화ST단태고성심기경사조(STEMI조),전부환자균채용면역속솔법측정혈청초민C반응단백수평,면역비탁법측정D-이취체수평,분석량자대림상심혈관불량사건발생적영향급기여관맥병변정도(Gensini적분)적관계。결과STEMI조초민C반응단백、D-이취체수평、단항여연합검측양성솔균명현고우SAP조、UAP조화NSTEMI조,NSTEMI조상술지표균명현고우SAP조화UAP조,UAP조상술지표균명현고우SAP조,조간비교차이유통계학의의(P<0.05),기중연합검측양성솔균명현고우단항검측양성솔,차이현저(P<0.05),고C수평조환자림상심혈관불량사건발생솔명현고우저C수평조,고D수평조환자림상심혈관불량사건발생솔명현고우저D수평조,구유현저차이(P<0.05),경Pearson상관분석발현,초민C반응단백여D-이취체정정상관(r=0.51,P=0.03),량자균여Gensini적분정정상관(r=0.46、0.52,P=0.04、0.03)。결론초민C반응단백、D-이취체재불동노년관심병분형중차이현저,량자균여관맥병변정도정정상관,차대림상심혈관불량사건발생구유중요적평고작용。
Objective To investigate the correlation between D-dimer and high sensitivity C reactive protein for elderly patients with coronary artery disease. Methods A total of 162 cases of elderly patients with coronary artery disease pa-tients were selected from internal geriatric department in our hospital, according to the classification, all patients were divided into stable angina pectoris (SAP group), coronary heart disease unstable angina pectoris (UAP group), non ST segment elevation myocardial infarction (NSTEMI group) and ST segment elevation myocardial infarction (STEMI group), all serum high sensitivity C reactive protein and D-dimer level were detected by immune turbidimetric method, the impact on clinical cardiovascular adverse events and the severity of coronary lesions (Gensini score) relationship were analyzed. Results High sensitive C reactive protein, D-dimer level of STEMI group single and combined detec-tion positive rate were significantly higher than SAP group, UAP group and NSTEMI group, the above indices of NSTE-MI group were significantly higher than SAP group and UAP group, the above indices of UAP group were significantly higher than SAP group with statistically significant differences between groups (P<0.05), the combined positive rate were significantly higher than single detection, compared with significance (P<0.05), clinical cardiovascular adverse events of high C levels group was significantly higher than low C group, high D group was significantly higher than low D group, compared with significant differences (P<0.05), the Pearson correlation analysis showed that, high sensitive C reactive protein and D-dimers were positively correlated (r=0.51, P=0.03), both of which were related to the Gensini score was positively(r=0.46, 0.52, P=0.04, 0.03). Conclusion High sensitivity C reactive protein, D-dimer are significant difference in different types of elderly coronary heart disease, both are positively correlated with the severity of coronary artery disease, and has an important role in the evaluation of occurrence of clinical adverse cardiovascular events.